Showing results (781-790 of 3,172) with videos related to

Sort By:
Pageof 318
Translational Oncology|November 27, 2022
The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell linesJeongjae Lee, Bhumsuk Keam, Soyeon Kim, et al.
Translational Oncology|July 12, 2022
Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer contextEmily Paterson, Cherie Blenkiron, Kirsty Danielson, et al.
Translational Oncology|October 8, 2021
Crosstalk between oral squamous cell carcinoma cells and cancer-associated fibroblasts via the TGF-β/SOX9 axis in cancer progressionKenta Haga, Manabu Yamazaki, Satoshi Maruyama, et al.
Translational Oncology|October 10, 2021
Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancerNarmeen S Rashid, Nicole S Hairr, Graeme Murray, et al.
Translational Oncology|April 8, 2022
Which evaluation criteria of the short-term efficacy can better reflect the long-term outcomes for patients with nasopharyngeal carcinoma?Li-Qin Ma, Hai-Xia Wu, Xiang-Quan Kong, et al.
Translational Oncology|April 28, 2022
Identification of IMPA2 as the hub gene associated with colorectal cancer and liver metastasis by integrated bioinformatics analysisLiuli Wang, Deming Liu, Shuo Liu, et al.
Translational Oncology|June 22, 2010
In vivo bioluminescent imaging of irradiated orthotopic pancreatic cancer xenografts in nonobese diabetic-severe combined immunodeficient mice: a novel method for targeting and assaying efficacy of ionizing radiationCheong J Lee, Aaron C Spalding, Edgar Ben-Josef, et al.
Translational Oncology|June 22, 2010
Limitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progressionChris P Miller, Karine Valliant-Saunders, Carl Anthony Blau
Translational Oncology|June 22, 2010
Strategies for high-resolution imaging of epithelial ovarian cancer by laparoscopic nonlinear microscopyRebecca M Williams, Andrea Flesken-Nikitin, Lora Hedrick Ellenson, et al.
Translational Oncology|August 7, 2010
Differential Antitumor Effects of IgG and IgM Monoclonal Antibodies and Their Synthetic Complementarity-Determining Regions Directed to New Targets of B16F10-Nex2 Melanoma CellsAndrey S Dobroff, Elaine G Rodrigues, Maria A Juliano, et al.
Pageof 318